Literature DB >> 2894030

Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma.

G Kovacs1, R Erlandsson, F Boldog, S Ingvarsson, R Müller-Brechlin, G Klein, J Sümegi.   

Abstract

Renal cell carcinoma (RCC) and normal kidney tissues have been examined from 34 patients with sporadic, nonhereditary RCC. Eighteen of the 21 cytogenetically examined tumors (86%) had a detectable anomaly of chromosome arm 3p distal to band 3p11.2-p13, manifested as a deletion, combined with the nonreciprocal translocation of a segment from another chromosome or monosomy 3. Restriction-fragment-length polymorphism analysis showed loss of D1S1 heterozygosity in 16 of the 21 cases (76%). D3S2 heterozygosity was lost in 2 of 11 cases (18%). The variability of the breakpoint between 3p11.2 and 3p13 and the absence of a consistently translocated segment from another chromosome suggests a genetic-loss mechanism, while the activation of a dominant oncogene appears less likely. Together with the previously demonstrated involvement of the 3p14.2 region in a familial case, these findings suggest that RCCs may arise by the deletion of a "recessive cancer gene," as do retinoblastoma and Wilms tumor. The relevant locus must be located on the telomeric side of the D1S1 locus on the short arm of chromosome 3.

Entities:  

Mesh:

Year:  1988        PMID: 2894030      PMCID: PMC279815          DOI: 10.1073/pnas.85.5.1571

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Involvement of band 3p14 in t(3;8) hereditary renal carcinoma.

Authors:  N Wang; K L Perkins
Journal:  Cancer Genet Cytogenet       Date:  1984-04

2.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

3.  Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells.

Authors:  S Pathak; L C Strong; R E Ferrell; A Trindade
Journal:  Science       Date:  1982-09-03       Impact factor: 47.728

4.  Localization of single copy DNA sequences of G-banded human chromosomes by in situ hybridization.

Authors:  M E Harper; G F Saunders
Journal:  Chromosoma       Date:  1981       Impact factor: 4.316

5.  Specific chromosome aberration in human renal cell carcinoma.

Authors:  G Kovacs; S Szücs; W De Riese; H Baumgärtel
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

6.  Rat c-myc oncogene is located on chromosome 7 and rearranges in immunocytomas with t(6:7) chromosomal translocation.

Authors:  J Sümegi; J Spira; H Bazin; J Szpirer; G Levan; G Klein
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

7.  Familial renal carcinoma.

Authors:  F P Li; D J Marchetto; R S Brown
Journal:  Cancer Genet Cytogenet       Date:  1982-11

8.  Restriction sites containing CpG show a higher frequency of polymorphism in human DNA.

Authors:  D Barker; M Schafer; R White
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

View more
  62 in total

1.  Linkage analysis of the Gi alpha 2 gene on mouse chromosome 9.

Authors:  J De Maeyer-Guignard; E De Maeyer
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Construction of a human chromosome 3 specific NotI linking library using a novel cloning procedure.

Authors:  E R Zabarovsky; F Boldog; T Thompson; D Scanlon; G Winberg; Z Marcsek; R Erlandsson; E J Stanbridge; G Klein; J Sümegi
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

Review 3.  Application of molecular cytogenetic techniques to the evaluation of renal parenchymal tumors.

Authors:  G Kovacs
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  Localization of the human HF.10 finger gene on a chromosome region (3p21-22) frequently deleted in human cancers.

Authors:  E Donti; L Lanfrancone; K Huebner; A Pascucci; G Venti; G Pengue; F Grignani; C M Croce; L Lania; P G Pelicci
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

5.  Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization.

Authors:  A Szeles; S Bajalica-Lagercrantz; A Lindblom; T Lushnikova; V I Kashuba; S Imreh; M Nordenskjöld; G Klein; E R Zabarovsky
Journal:  Chromosome Res       Date:  1996-06       Impact factor: 5.239

6.  Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.

Authors:  P Hadaczek; J Podolski; A Toloczko; G Kurzawski; A Sikorski; P Rabbitts; K Huebner; J Lubinski
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

7.  Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; W Thoenes; H E Gabbert
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.

Authors:  Y Suzuki; G Tamura; C Maesawa; T Fujioka; T Kubo; R Satodate
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.

Authors:  E R Maher; J R Yates; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

Review 10.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.